Current Therapeutic Strategies for Anticoagulation in COVID 19 Associated Thromboembolic Disease | Panel Discussion

Thromboembolism resulting from post-Covid-19 infections has resulted in an increased mortality rate. Studies suggest the presence of thrombogenic potential in SARS-CoV-2 originating from inflammatory response leading to a reduction in the anticoagulatory potential of the endothelium. Anticoagulants have been the preferred choice for the treatment of thromboembolism but no standard consensus has been documented for the dosage or duration of anticoagulation therapy. This online program on our... Read more